Drug Development Services

CRI Lifetree seeks to partner with companies in both the biotechnology and pharmaceutical sector in an effort to become an indispensable drug development partner. Our clinical and regulatory thought leaders at CRI Lifetree provide clients with a proven track record of successful drug development in the US with multiple INDs in pain. Our full IND services offer preclinical compound assessment, evaluation of animal pharmacology, preparation for first in human trials and document preparation. CRI Lifetree has direct experience with the current regulatory environment and review division personnel in alternative formulations, alternate routes of delivery, combination drug products, and abuse liability.

At CRI Lifetree we have the ability to design and development programs to best reach the market in the prevailing regulatory environment: Phase I first in human trials, first-look/surrogate efficacy endpoints, experimental pain models, and proof of concept programs.